HF
ANIK icon

HRT Financial’s Anika Therapeutics ANIK Stock Holding History

HRT Financial’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,313
Closed -$230K – 2392
2024
Q3 		$230K Buy
+9,313
New +$241K ﹤0.01% 1916
2024
Q1 		– Sell
-40,916
Closed -$927K – 2266
2023
Q4 		$927K Sell
40,916
-17,407
-30% -$360K 0.01% 1030
2023
Q3 		$1.09M Buy
+58,323
New +$1.21M 0.01% 926
2023
Q2 		– Sell
-11,382
Closed -$326K – 2423
2023
Q1 		$326K Sell
11,382
-15,177
-57% -$452K ﹤0.01% 1668
2022
Q4 		$786K Buy
+26,559
New +$755K 0.01% 1111
2021
Q4 		– Sell
-9,329
Closed -$397K – 3128
2021
Q3 		$397K Buy
9,329
+1,224
+15% +$50.4K ﹤0.01% 2213
2021
Q2 		$350K Buy
+8,105
New +$345K ﹤0.01% 2043
2021
Q1 		– Sell
-6,525
Closed -$295K – 2658
2020
Q4 		$295K Buy
6,525
+825
+14% +$31.3K 0.01% 1292
2020
Q3 		$201K Buy
+5,700
New +$206K 0.01% 1363
2019
Q4 		– Sell
-7,836
Closed -$430K – 1134
2019
Q3 		$430K Buy
+7,836
New +$402K 0.02% 756

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

HRT Financial's ANIK Position: Q4 2024 in Review

HRT Financial sold out of Anika Therapeutics (ANIK) in Q4 2024, closing a stake of 9,313 shares — an estimated $230K sold.

HRT Financial first reported a position in ANIK in Q3 2019 and held it in 10 quarters. The position peaked at $1.09M in Q3 2023. 109 funds tracked by Wall St. Rank hold ANIK as of Q4 2024.

  • HRT Financial reported no remaining Anika Therapeutics position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 9,313 Anika Therapeutics shares in Q4 2024, an estimated $230K.
  • HRT Financial first reported a position in Anika Therapeutics in Q3 2019 and held it in 10 quarters.
  • HRT Financial's Anika Therapeutics position peaked at $1.09M in Q3 2023.
  • 109 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.